Bright Minds Biosciences, Inc. (DRUG.CX)
108.64
-2.39
(-2.15%)
CAD |
CNSX |
Mar 03, 15:48
Bright Minds Biosciences Cash from Investing (Quarterly) : 0.00 for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.816M |
| Cash from Financing (Quarterly) | 13.39M |
| Free Cash Flow | -13.01M |
| Free Cash Flow Per Share (Quarterly) | -0.7493 |
| Free Cash Flow to Equity (Quarterly) | -5.795M |
| Free Cash Flow to Firm (Quarterly) | -5.809M |
| Free Cash Flow Yield | -1.65% |